CARE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Carter Bankshares Inc (CARE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows regional growth potential and improving financial metrics, the lack of strong technical signals, neutral trading sentiment, and mixed financial performance suggest holding off on immediate investment.
The MACD is below zero and negatively contracting, indicating weak momentum. RSI is neutral at 50.592, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting a lack of strong directional trend. Key support and resistance levels are at 21.015 and 22.214, respectively, with the current price near the pivot point at 21.615.
Analyst rating from Freedom Capital initiated with a Buy and a $23 price target, citing regional growth, loan expansion, and improving margins. Revenue increased by 14.91% YoY in Q3 2025.
No significant insider or hedge fund trading trends. No recent news or congress trading data. Neutral technical indicators and lack of strong directional momentum.
In Q3 2025, revenue increased by 14.91% YoY to $36.76 million, but net income dropped by -3.95% YoY to $5.35 million. EPS remained flat at 0.24 YoY.
Freedom Capital initiated coverage with a Buy rating and a $23 price target, highlighting Carter Bankshares' regional growth potential and improving profitability metrics.
